A
Price
$125.66
Change
+$0.70 (+0.56%)
Updated
Aug 29 closing price
Capitalization
35.7B
92 days until earnings call
EMBC
Price
$14.48
Change
-$0.02 (-0.14%)
Updated
Aug 29 closing price
Capitalization
846.86M
114 days until earnings call
Interact to see
Advertisement

A vs EMBC

Header iconA vs EMBC Comparison
Open Charts A vs EMBCBanner chart's image
Agilent Technologies
Price$125.66
Change+$0.70 (+0.56%)
Volume$1.78M
Capitalization35.7B
Embecta
Price$14.48
Change-$0.02 (-0.14%)
Volume$366.81K
Capitalization846.86M
A vs EMBC Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. EMBC commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and EMBC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (A: $125.66 vs. EMBC: $14.48)
Brand notoriety: A and EMBC are both not notable
A represents the Medical Specialties, while EMBC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 110% vs. EMBC: 59%
Market capitalization -- A: $35.7B vs. EMBC: $846.86M
A [@Medical Specialties] is valued at $35.7B. EMBC’s [@Pharmaceuticals: Other] market capitalization is $846.86M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileEMBC’s FA Score has 2 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • EMBC’s FA Score: 2 green, 3 red.
According to our system of comparison, EMBC is a better buy in the long-term than A.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while EMBC’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 3 bearish.
  • EMBC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both A and EMBC are a good buy in the short-term.

Price Growth

A (@Medical Specialties) experienced а +3.31% price change this week, while EMBC (@Pharmaceuticals: Other) price change was +1.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.46%. For the same industry, the average monthly price growth was +7.37%, and the average quarterly price growth was +8.13%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.93%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +26.47%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

EMBC is expected to report earnings on Dec 23, 2025.

Industries' Descriptions

@Medical Specialties (-0.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($35.7B) has a higher market cap than EMBC($847M). A has higher P/E ratio than EMBC: A (29.36) vs EMBC (10.20). A YTD gains are higher at: -6.065 vs. EMBC (-27.377). A has higher annual earnings (EBITDA): 1.76B vs. EMBC (252M). EMBC has less debt than A: EMBC (1.55B) vs A (3.5B). A has higher revenues than EMBC: A (6.63B) vs EMBC (1.1B).
AEMBCA / EMBC
Capitalization35.7B847M4,215%
EBITDA1.76B252M698%
Gain YTD-6.065-27.37722%
P/E Ratio29.3610.20288%
Revenue6.63B1.1B601%
Total Cash1.49BN/A-
Total Debt3.5B1.55B225%
FUNDAMENTALS RATINGS
A: Fundamental Ratings
A
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
51
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AEMBC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SAMM27.71N/A
N/A
Strategas Macro Momentum ETF
PZA22.19-0.03
-0.14%
Invesco National AMT-Free Muni Bd ETF
ISRA52.47-0.18
-0.35%
VanEck Israel ETF
HPI16.05-0.06
-0.35%
John Hancock Preferred Income Fund
TLTP22.23-0.10
-0.47%
Amplify Bloomberg U.S.Trs 12% Prm IncETF

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with WAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+0.91%
WAT - EMBC
37%
Loosely correlated
+1.39%
MTD - EMBC
37%
Loosely correlated
+1.40%
RVTY - EMBC
36%
Loosely correlated
+0.99%
A - EMBC
35%
Loosely correlated
+0.56%
AZTA - EMBC
34%
Loosely correlated
+2.07%
More